Mandatum Life Insurance Company’s Colgate-Palmolive CL Stock Holding History

Mandatum Life Insurance Company’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.77M	Hold	32,500	–	–	0.62%	32
2025 Q4	$2.57M	Hold	32,500	–	–	0.59%	33
2025 Q3	$2.6M	Hold	32,500	–	–	0.62%	33
2025 Q2	$2.95M	Hold	32,500	–	–	0.78%	29
2025 Q1	$3.05M	Hold	32,500	–	–	0.94%	28
2024 Q4	$2.95M	Hold	32,500	–	–	0.88%	25
2024 Q3	$3.37M	Hold	32,500	–	–	1.04%	23
2024 Q2	$3.15M	Hold	32,500	–	–	1.06%	23
2024 Q1	$2.93M	Hold	32,500	–	–	0.98%	21
2023 Q4	$2.59M	Hold	32,500	–	–	0.96%	24
2023 Q3	$2.31M	Hold	32,500	–	–	0.96%	23
2023 Q2	$2.5M	Hold	32,500	–	–	1.04%	23
2023 Q1	$2.44M	Hold	32,500	–	–	0.72%	25
2022 Q4	$2.56M	Buy	32,500 +2,500	+8%	+$187K	0.78%	24
2022 Q3	$2.11M	Hold	30,000	–	–	0.67%	25
2022 Q2	$2.4M	Buy	30,000 +2,294	+8%	+$179K	0.54%	27
2022 Q1	$2.1M	Buy	27,706 +10,988	+66%	+$870K	0.39%	29
2021 Q4	$1.43M	Sell	16,718 -77,700	-82%	-$6.07M	0.38%	38
2021 Q3	$7.14M	Hold	94,418	–	–	1.32%	18
2021 Q2	$7.68M	Hold	94,418	–	–	1.39%	13
2021 Q1	$7.44M	Hold	94,418	–	–	1.47%	12
2020 Q4	$8.07M	Hold	94,418	–	–	1.68%	9
2020 Q3	$7.28M	Hold	94,418	–	–	1.6%	11
2020 Q2	$6.92M	Sell	94,418 -9,679	-9%	-$688K	1.66%	10
2020 Q1	$6.91M	Buy	104,097 +77,700	+294%	+$5.48M	1.85%	9
2019 Q4	$1.82M	Sell	26,397 -578	-2%	-$39.4K	0.38%	68
2019 Q3	$1.98M	Buy	26,975 +1,409	+6%	+$102K	0.4%	61
2019 Q2	$1.83M	Buy	25,566 +2,929	+13%	+$208K	0.38%	60
2019 Q1	$1.55M	Buy	22,637 +769	+4%	+$49.7K	0.34%	65
2018 Q4	$1.3M	Buy	21,868 +4,154	+23%	+$260K	0.31%	65
2018 Q3	$1.19M	Buy	17,714 +2,736	+18%	+$182K	0.23%	74
2018 Q2	$971K	Buy	14,978 +162	+1%	+$10.6K	0.19%	78
2018 Q1	$1.06M	Buy	14,816 +709	+5%	+$51K	0.2%	71
2017 Q4	$1.06M	Sell	14,107 -1,000	-7%	-$73K	0.17%	80
2017 Q3	$1.1M	Sell	15,107 -5,019	-25%	-$362K	0.15%	81
2017 Q2	$1.49M	Sell	20,126 -1,438	-7%	-$107K	0.2%	68
2017 Q1	$1.58M	Sell	21,564 -635	-3%	-$44.4K	0.21%	79
2016 Q4	$1.45M	Buy	22,199 +943	+4%	+$64.7K	0.2%	79
2016 Q3	$1.58M	Buy	21,256 +3,046	+17%	+$225K	0.21%	73
2016 Q2	$1.33M	Buy	18,210 +1,553	+9%	+$111K	0.18%	79
2016 Q1	$1.18M	Buy	16,657 +3,382	+25%	+$225K	0.16%	82
2015 Q4	$884K	Buy	+13,275	New	+$883K	0.12%	96

Other funds holding CL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Mandatum Life Insurance Company's CL Position: Q1 2026 in Review

Mandatum Life Insurance Company held its Colgate-Palmolive (CL) position steady in Q1 2026 at 32,500 shares worth $2.77M. The position accounts for 0.62% of the portfolio, ranked #32.

Mandatum Life Insurance Company first reported a position in CL in Q4 2015 and has held it in 42 quarters since. The position peaked at $8.07M in Q4 2020. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

Mandatum Life Insurance Company held 32,500 shares of Colgate-Palmolive worth $2.77M as of Q1 2026.
Mandatum Life Insurance Company left its Colgate-Palmolive share count unchanged in Q1 2026.
Colgate-Palmolive made up 0.62% of Mandatum Life Insurance Company's portfolio in Q1 2026, its #32 holding.
Mandatum Life Insurance Company first reported a position in Colgate-Palmolive in Q4 2015 and has held it in 42 quarters since.
Mandatum Life Insurance Company's Colgate-Palmolive position peaked at $8.07M in Q4 2020.
1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Mandatum Life Insurance Company's 13F filing for Q1 2026, filed 5 May 2026.